**Core Concept**
Gemcitabine is a nucleoside analog that acts as a cell cycle-specific antineoplastic agent, primarily inhibiting DNA synthesis. It is metabolized intracellularly to its active metabolites, which are then incorporated into DNA, causing chain termination and apoptosis in rapidly dividing cancer cells.

**Why the Correct Answer is Right**
Gemcitabine is effective in various types of cancers, including pancreatic cancer, non-small cell lung cancer, breast cancer, ovarian cancer, and bladder cancer. It works by inhibiting ribonucleotide reductase, an enzyme essential for DNA synthesis, thereby inducing cell cycle arrest and apoptosis. The active metabolites of gemcitabine, dFdCTP and dFdUTP, are incorporated into DNA, causing DNA strand breaks and inhibiting DNA repair mechanisms.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because while gemcitabine can be used in combination with other chemotherapeutic agents, it is not primarily effective in treating renal cell carcinoma.
**Option B:** This option is incorrect because gemcitabine is not a first-line treatment for hepatocellular carcinoma.
**Option C:** This option is incorrect because while gemcitabine has some activity in gastrointestinal stromal tumors, it is not the primary treatment of choice.

**Clinical Pearl / High-Yield Fact**
Gemcitabine is often used in combination with other chemotherapeutic agents, such as cisplatin, to enhance its efficacy and reduce toxicity. It is essential to monitor liver function and renal function closely when administering gemcitabine, as it can cause hepatotoxicity and nephrotoxicity.

**Correct Answer: D.**